Risk factors for tumor recurrence after breast conserving therapy: About 254 cases

被引:1
作者
Chauleur, C. [1 ]
Vulliez, L. [1 ]
Trombert, B. [2 ]
Raoux, D. [3 ]
Khaddage, A. [3 ]
Seffert, P. [1 ]
机构
[1] CHU St Etienne, Hop Nord, Serv Gynecol Obstet, F-42270 St Priest En Jarez, France
[2] CHU St Etienne, Hop St Jean de Bonnefonds, Serv Sante Publ, F-42055 St Etienne 2, France
[3] CHU St Etienne, Hop Nord, Lab Anatomopathol, F-42270 St Priest En Jarez, France
来源
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION | 2008年 / 37卷 / 02期
关键词
Breast cancer; Recurrence; Risk factor; Conserving therapy;
D O I
10.1016/j.jgyn.2007.11.027
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives. - To retrospectively study our risk factors of recurrence of infiltrating breast cancers treated by conservative therapy in Saint-Etienne university hospital. Materials and methods. - From 1997 to 2000, 254 patients were treated by conservative treatment. Through a univariate then multivariate analysis we identified factors of locoregional and metastatic recurrences. Results. - The global rate of recurrence is 21.6%. There is 9.8% of local recurrence, 2.3% of node recurrence and 14.9% of metastatic one. Plurifocality OR: 3.7, tumoral type OR: 2.93, lymphovascular invasion OR: 3.6 and young age are factors of locoregional recurrence. For distant metastases, the recurrences factors are the tumoral size, the node status, the absence of estrogens receptors, the SBR rank, the locoregional recurrence, the rise of CA 15-3 and the addition of chemotherapy but only the SBR rank OR: 2.56 appears in multivariate analysis. Conclusion. - On one hand, this study revealed known risk factors already used to decide on the adjuvant therapy. On the other hand, plurifocality and lobular cancer must be taken into consideration before a conservative therapy. The surgery will probably be more extensive under these conditions. (C) 2007 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:170 / 178
页数:9
相关论文
共 30 条
  • [1] Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
  • [2] Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy
    Cheng, JCH
    Chen, CM
    Liu, MC
    Tsou, MH
    Yang, PS
    Jian, JJM
    Cheng, SH
    Tsai, SY
    Leu, SY
    Huang, AT
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (04): : 980 - 988
  • [3] Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy
    Dunst, J
    Steil, B
    Furch, S
    Fach, A
    Lautenschläger, C
    Diestelhorst, A
    Lampe, D
    Kölbl, H
    Richter, C
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (10) : 504 - 510
  • [4] Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: Patterns of recurrence
    Fisher, BJ
    Perera, FE
    Cooke, AL
    Opeitum, A
    Venkatesan, V
    Dar, AR
    Stitt, L
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (03): : 541 - 550
  • [5] Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: An indication for radiotherapy?
    Fisher, BJ
    Perera, FE
    Cooke, AL
    Opeitum, A
    Dar, AR
    Venkatesan, VM
    Stitt, L
    Radwan, JS
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (03): : 551 - 559
  • [6] Fodor J, 2001, Magy Seb, V54, P209
  • [7] Fodor J, 2003, STRAHLENTHER ONKOL, V179, P197, DOI 10.1007/s00066-003-1010-7
  • [8] FODOR J, 2005, MAGY ONKOL, V49, P5
  • [9] Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy
    Freedman, G
    Fowble, B
    Hanlon, A
    Nicolaou, N
    Fein, D
    Hoffman, J
    Sigurdson, E
    Boraas, M
    Goldstein, L
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (05): : 1005 - 1015
  • [10] A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger
    Freedman, GM
    Fowble, BL
    Hanlon, AL
    Myint, MA
    Hoffman, JP
    Sigurdson, ER
    Eisenberg, BL
    Goldstein, LJ
    Fein, DA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (03): : 599 - 605